Pharming Group N.V.: Form 20-F for the period ended Dec 31, 2020
Filed with the SEC on Apr 7, 2021 and accepted by EDGAR at Apr 7, 2021, 16:22 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Shares outstanding | At period end2020-12-31 | 638,821,619 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001628280-21-006652. Last ingested by Listed: Nov 6, 2026, 11:08 ET. Listed shows no prices and gives no investment advice.